Almac announces completion of two new facilities as part of £400m expansion
Read more
Almac announces completion of two new facilities as part of £400m expansion
Read more
Almac Group signs power purchase agreement (PPA) with NTR for renewable energy
Learn more
Almac Group releases 2023 Corporate Social Responsibility Report
Read more
Want to play a part in advancing human health?
Join us
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
7000
Employees globally
50%+
Contributed to over half of approved NMEs in the last 6 years
50+
Years’ experience
25
Work with top 25 BioPharma companies
18
Facilities globally
Latest from Almac
Partnering to advance human health
Explore our locationsAlmac Discovery
Almac Discovery is a research driven drug discovery company dedicated to the development of novel and innovative therapeutics using cutting edge research techniques to develop First in Class preclinical stage assets.
Find out more
Diagnostic Services
Almac Diagnostic Services is our precision medicine business unit, supporting global pharma and biotech companies to deliver on their biomarker strategies.
Find out more
Pharmaceutical Development & Manufacturing Services
We are trusted experts in API Manufacture, Formulation Development, Clinical Trial Supply Services and Technologies through to Commercial-Scale Manufacture and Distribution.
Find out more
Developing and marketing pharmaceuticals globally
Galen, part of the Almac Group, is a global pharmaceutical company selling medicines worldwide, and partners with like-minded companies to accomplish this.
Find out more